Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. prisoner or institutionalized patient 2. unable to give informed consent 3. less than 18 years of age 4. hospitalization 5. active bleeding requiring blood products in past week 6. diagnosed with bipolar disorder and not on mood stabilizing medication 7. known allergy or hypersensitivity to fluoxetine 8. currently taking a monoamine oxidase inhibitor (maoi) 9. currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) 10. outpatient and currently taking hydroxychloroquine 11. known pregnancy 12. breastfeeding 13. known prolonged qtc, such as congenital prolonged qtc syndromes

1. prisoner or institutionalized patient 2. unable to give informed consent 3. less than 18 years of age 4. hospitalization 5. active bleeding requiring blood products in past week 6. diagnosed with bipolar disorder and not on mood stabilizing medication 7. known allergy or hypersensitivity to fluoxetine 8. currently taking a monoamine oxidase inhibitor (maoi) 9. currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) 10. outpatient and currently taking hydroxychloroquine 11. known pregnancy 12. breastfeeding 13. known prolonged qtc, such as congenital prolonged qtc syndromes

Nov. 16, 2021, 6:30 p.m. usa

prisoner or institutionalized patient unable to give informed consent less than 18 years of age hospitalization active bleeding requiring blood products in past week diagnosed with bipolar disorder and not on mood stabilizing medication known allergy or hypersensitivity to fluoxetine currently taking a monoamine oxidase inhibitor (maoi) currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) outpatient and currently taking hydroxychloroquine known pregnancy breastfeeding known prolonged qtc, such as congenital prolonged qtc syndromes

prisoner or institutionalized patient unable to give informed consent less than 18 years of age hospitalization active bleeding requiring blood products in past week diagnosed with bipolar disorder and not on mood stabilizing medication known allergy or hypersensitivity to fluoxetine currently taking a monoamine oxidase inhibitor (maoi) currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) outpatient and currently taking hydroxychloroquine known pregnancy breastfeeding known prolonged qtc, such as congenital prolonged qtc syndromes

Oct. 26, 2020, 11:31 p.m. usa

1. prisoner or institutionalized patient 2. unable to give informed consent 3. less than 18 years of age 4. hospitalization 5. active bleeding requiring blood products in past week 6. diagnosed with bipolar disorder and not on mood stabilizing medication 7. known allergy or hypersensitivity to fluoxetine 8. currently taking a monoamine oxidase inhibitor (maoi) 9. currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) 10. outpatient and currently taking hydroxychloroquine 11. known pregnancy 12. breastfeeding 13. known prolonged qtc, such as congenital prolonged qtc syndromes

1. prisoner or institutionalized patient 2. unable to give informed consent 3. less than 18 years of age 4. hospitalization 5. active bleeding requiring blood products in past week 6. diagnosed with bipolar disorder and not on mood stabilizing medication 7. known allergy or hypersensitivity to fluoxetine 8. currently taking a monoamine oxidase inhibitor (maoi) 9. currently taking an selective serotonin reuptake inhibitor (ssri) or selective norepinephrine reuptake inhibitor (snri) 10. outpatient and currently taking hydroxychloroquine 11. known pregnancy 12. breastfeeding 13. known prolonged qtc, such as congenital prolonged qtc syndromes